Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Tesar

Showing results (91-100 of 193) with videos related to

Pageof 20
Sort By:
Kidney International|October 21, 2022
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathyJonathan Barratt, Richard Lafayette, Jens Kristensen, et al.
The Lancet. Diabetes & Endocrinology|August 14, 2015
The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trialDick de Zeeuw, Pirow Bekker, Elena Henkel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 24, 2010
Association of advanced vasculopathy and transforming growth factor-beta1 gene expression with immunoglobulin A nephropathy progressionIrena Brabcova, Vladimir Tesar, Eva Honsova, et al.
American Journal of Nephrology|November 26, 2018
Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody GlomerulonephritisSteven Menez, Zdenka Hruskova, Jennifer Scott, et al.
Kidney & Blood Pressure Research|April 18, 2008
Prevalence and risk of hypertension in renal disease--data from the Czech Registry of Renal BiopsiesEva Jancova, Zdenka Vankova, Eva Honsova, et al.
Journal of Nephrology|April 24, 2014
Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994-2011Dita Maixnerova, Eva Jancova, Jelena Skibova, et al.
Renal Failure|February 24, 2025
Right ventricular-pulmonary arterial coupling and pulmonary hypertension in hemodialysis: insights into structural cardiac changes and clinical implicationsKristina Buryskova Salajova, Jan Malik, Lucie Kaiserova, et al.
Frontiers in Medicine|June 15, 2026
Beyond fluid overload: uncovering the hidden causes of dyspnea in hemodialysis patientsKristina Buryskova Salajova, Jan Malik, Eva Strakova, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 12, 2014
Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP)Richard Haynes, Natalie Staplin, Jonathan Emberson, et al.
American Journal of Nephrology|June 6, 2015
Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximabShivani Shah, Zdenka Hruskova, Marten Segelmark, et al.
Pageof 20

Showing results (91-100 of 193) with videos related to

Sort By:
Pageof 20
Kidney International|October 21, 2022
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathyJonathan Barratt, Richard Lafayette, Jens Kristensen, et al.
The Lancet. Diabetes & Endocrinology|August 14, 2015
The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trialDick de Zeeuw, Pirow Bekker, Elena Henkel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 24, 2010
Association of advanced vasculopathy and transforming growth factor-beta1 gene expression with immunoglobulin A nephropathy progressionIrena Brabcova, Vladimir Tesar, Eva Honsova, et al.
American Journal of Nephrology|November 26, 2018
Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody GlomerulonephritisSteven Menez, Zdenka Hruskova, Jennifer Scott, et al.
Kidney & Blood Pressure Research|April 18, 2008
Prevalence and risk of hypertension in renal disease--data from the Czech Registry of Renal BiopsiesEva Jancova, Zdenka Vankova, Eva Honsova, et al.
Journal of Nephrology|April 24, 2014
Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994-2011Dita Maixnerova, Eva Jancova, Jelena Skibova, et al.
Renal Failure|February 24, 2025
Right ventricular-pulmonary arterial coupling and pulmonary hypertension in hemodialysis: insights into structural cardiac changes and clinical implicationsKristina Buryskova Salajova, Jan Malik, Lucie Kaiserova, et al.
Frontiers in Medicine|June 15, 2026
Beyond fluid overload: uncovering the hidden causes of dyspnea in hemodialysis patientsKristina Buryskova Salajova, Jan Malik, Eva Strakova, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 12, 2014
Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP)Richard Haynes, Natalie Staplin, Jonathan Emberson, et al.
American Journal of Nephrology|June 6, 2015
Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximabShivani Shah, Zdenka Hruskova, Marten Segelmark, et al.
Pageof 20